Mode
Text Size
Log in / Sign up

Allergy & Immunology

493 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Measures for COVID-19 prevention and treatment in immunocompromised persons reviewed
Allergy & Immunology
Measures for COVID-19 prevention and treatment in immunocompromised persons reviewed How can immunocompromised people protect themselves from COVID-19?
A review of measures for SARS-CoV-2 infection in immunocompromised persons in the United States is presented.
Immunocompromised people need tailored strategies to prevent and treat COVID-19, but a new report says we still lack concrete evidence on th…
ACIP Recommends Nirsevimab for Severe RSV Prevention in Infants and Young Children
Allergy & Immunology
ACIP Recommends Nirsevimab for Severe RSV Prevention in Infants and Young Children Should more infants get protection against severe RSV?
The Advisory Committee on Immunization Practices (ACIP) has issued a recommendation for using nirsevimab to prevent severe respiratory syncy…
A national health committee now recommends a preventive shot called nirsevimab to help infants avoid severe breathing problems caused by the…
Guideline update finds women at high HIV risk eligible for all hormonal contraceptives and IUDs
Allergy & Immunology
Guideline update finds women at high HIV risk eligible for all hormonal contraceptives and IUDs Can women at high risk for HIV safely use hormonal birth control?
A guideline update indicates women at high risk for HIV infection are eligible to use all hormonal contraceptive methods and intrauterine de…
Women at high risk for HIV can safely use all hormonal birth control and IUDs without restrictions.
Japanese Encephalitis Vaccine Recommended as Key Prevention in Asia
Allergy & Immunology
Japanese Encephalitis Vaccine Recommended as Key Prevention in Asia Japanese encephalitis vaccine prevents most common cause of brain infection in Asia
A recommendation report identifies Japanese encephalitis virus as the most common vaccine-preventable cause of encephalitis in Asia.
Japanese encephalitis is the most common vaccine-preventable cause of brain infection in Asia, making vaccination a key protection for trave…
Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% between 2007 and 2018
Allergy & Immunology
Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% between 2007 and 2018 Are more kids developing food allergies? Survey shows a concerning rise
A US national survey found the percentage of children aged 0-17 years reporting a food or digestive allergy in the past 12 months increased …
From 2007 to 2018, the percentage of American children with food or digestive allergies rose from 4.0% to 6.5%, meaning more kids now face t…
ACIP concludes benefits of mRNA COVID-19 vaccination outweigh myocarditis risks
Allergy & Immunology
ACIP concludes benefits of mRNA COVID-19 vaccination outweigh myocarditis risks Health panel says COVID-19 vaccine benefits outweigh rare myocarditis risk
An advisory committee review of mRNA COVID-19 vaccines in the US, following reports of myocarditis, concluded vaccination benefits outweigh …
A U.S. health panel concludes that COVID-19 vaccine benefits outweigh the rare risk of heart inflammation in people who get vaccinated.
2023 adult immunization schedule updates published for US adults aged 19+
Allergy & Immunology
2023 adult immunization schedule updates published for US adults aged 19+ CDC updates 2023 adult immunization schedule with vaccine-specific changes
A publication outlines vaccine-specific changes to the 2023 immunization schedule for US adults aged 19 years or older.
The CDC updated the 2023 adult vaccine schedule with specific changes to recommendations for certain shots for people aged 19 and older.
ACIP Issues Recommendations for Seasonal Influenza Prevention and Control with Vaccines
Allergy & Immunology
ACIP Issues Recommendations for Seasonal Influenza Prevention and Control with Vaccines What's the latest advice on flu shots this season?
The Advisory Committee on Immunization Practices (ACIP) has published recommendations for the prevention and control of seasonal influenza u…
U.S. health officials released updated flu shot advice for the 2023-24 season, emphasizing vaccination as the core way to prevent and contro…
HIV/AIDS continues disproportionate impact on U.S. Black or African American population
Allergy & Immunology
HIV/AIDS continues disproportionate impact on U.S. Black or African American population HIV and AIDS continue to disproportionately affect Black Americans, awareness day notes
A non-research announcement for National Black HIV/AIDS Awareness Day notes the continuing disproportionate impact of HIV infection and AIDS…
National Black HIV/AIDS Awareness Day highlights that HIV and AIDS continue to disproportionately affect Black or African American people in…
Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% over 11 years
Allergy & Immunology
Survey shows food allergy prevalence in US children rose from 4.0% to 6.5% over 11 years Survey finds more U.S. children reported having food allergies over an 11-year period
A US observational survey of children aged 0-17 years found the percentage reporting a food or digestive allergy in the past 12 months incre…
Reports of childhood food allergies in the U.S. rose from 4.0% in 2007 to 6.5% in 2018, showing more kids affected over 11 years.
Survey finds higher current asthma prevalence among US adult women compared to men
Allergy & Immunology
Survey finds higher current asthma prevalence among US adult women compared to men Survey finds adult women in the US more likely to have asthma than men
A US National Health Interview Survey analysis of adults aged ≥18 years found women were more likely than men to currently have asthma.
A 2017-2018 national survey shows adult women in the US are more likely than men to currently have asthma.
Surveillance reports anaphylaxis cases after first Moderna COVID-19 vaccine doses in US
Allergy & Immunology
Surveillance reports anaphylaxis cases after first Moderna COVID-19 vaccine doses in US What happens when people have severe allergic reactions to the Moderna vaccine?
A US surveillance report describes cases of anaphylaxis following first doses of the Moderna COVID-19 vaccine.
Health officials report severe allergic reactions, including anaphylaxis, after people received their first dose of the Moderna COVID-19 vac…